August 10, 2021 07:23 AM EDT

Covid-19 roundup: New study suggests Moderna vaccine may be more effective than Pfizer against the Delta variant; Pentagon to require vaccines for members of the military

Nicole DeFeudis

Editor

A study of patients in the Mayo Clinic Health System across multiple states suggests those who received Pfizer’s Covid-19 vaccine are at a two-fold higher …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: New study suggests Moderna vaccine may be more effective than Pfizer against the Delta variant; Pentagon to require vaccines for members of the military

Nicole DeFeudis

Editor

Sign up to read this article for free.

Novartis to cut 139 jobs in NJ as part of commercial refocus

Applied Therapeutics' rare disease drug gets a CRL

Idorsia eyes layoffs, tees up Tryvio licensing deal to extend cash runway

FDA is looking into hematology risks after patients take Bluebird's Skysona gene therapy

Advanz Pharma faces revocation of European authorization for liver disease drug Ocaliva

PTC reports Phase 2 ALS fail, sells priority review voucher for $150M

Covid-19 roundup: New study sug­gests Mod­er­na vac­cine may be more ef­fec­tive than Pfiz­er against the Delta vari­ant; Pen­ta­gon to re­quire vac­cines for mem­bers of the mil­i­tary

Nicole DeFeudis

Editor

Sign up to read this article for free.

more like this

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

Idor­sia eyes lay­offs, tees up Tryvio li­cens­ing deal to ex­tend cash run­way

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Ad­vanz Phar­ma faces re­vo­ca­tion of Eu­ro­pean au­tho­riza­tion for liv­er dis­ease drug Ocali­va

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Covid-19 roundup: New study suggests Moderna vaccine may be more effective than Pfizer against the Delta variant; Pentagon to require vaccines for members of the military

Novartis to cut 139 jobs in NJ as part of commercial refocus

Applied Therapeutics' rare disease drug gets a CRL

Idorsia eyes layoffs, tees up Tryvio licensing deal to extend cash runway

FDA is looking into hematology risks after patients take Bluebird's Skysona gene therapy

Advanz Pharma faces revocation of European authorization for liver disease drug Ocaliva

PTC reports Phase 2 ALS fail, sells priority review voucher for $150M